Table I. Association between autoantibodies to AQP1 and salivary flow rates.
| Presence of autoantibodies | Number of patients | Mean (95% CI) | p |
|---|---|---|---|
| Anti-AQP1 IgG | |||
| Resting salivary flow | |||
| − | 74 | 0.068 (0.041, 0.094) | 0.449a |
| + | 17 | 0.047 (0.023, 0.071) | 0.838b |
| Stimulated salivary flow | |||
| − | 71 | 0.518 (0.403, 0.633) | 0.821a |
| + | 17 | 0.547 (0.319, 0.776) | 0.604b |
| Anti-AQP1 IgA | |||
| Resting salivary flow | |||
| − | 83 | 0.064 (0.042, 0.087) | 0.814a |
| + | 5 | 0.054 (−0.051, 0.159) | 0.674b |
| Stimulated salivary flow | |||
| − | 83 | 0.534 (0.430, 0.638) | 0.394a |
| + | 5 | 0.347 (−0.255, 0.949) | 0.194b |
| Anti-AQP1 IgG or IgA in patients who were positive for anti-AQP5 autoantibodies | |||
| Resting salivary flow | |||
| − | 49 | 0.050 (0.025, 0.074) | 0.894a |
| + | 19 | 0.045 (0.020, 0.071) | 0.599b |
| Stimulated salivary flow | |||
| − | 49 | 0.517 (0.374, 0.660) | 0.840a |
| + | 19 | 0.485 (0.275, 0.694) | 0.885b |
aANOVA, bMann-Whitney.